doi:10.2903/j.efsa.2024.8819 Lafuente R, Gonzlez-Comadrn M, Sol I, et al
They will have multi-asset portfolios across injectables, oral therapies, dual agonists, triple agonists, amylin combinations, cardiometabolic indications, and scalable global supply
*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
It is one of the most extensively investigated and popular antioxidants, renowned for its ability to increase immunity, help in collagen formation, and improve skin health
In the UK, Ozempic is licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) and is recommended by the National Institute for Health and Care Excellence (NICE) in guideline NG28 for adults with type 2 diabetes